Somatostatin Receptors as Molecular Targets in Human Uveal Melanoma

Kristof Harda1, Zsuzsanna Szabo2, Erzsebet Szabo3

  • 1Department of Biopharmacy, University of Debrecen, 4032 Debrecen, Hungary. harda.kristof@pharm.unideb.hu.

Insights

Uveal melanoma (UM) is a rare eye cancer. This study found that somatostatin receptors (SSTRs), specifically SSTR-2 and SSTR-5, are expressed in UM tissues and cell lines, suggesting they are potential therapeutic targets.

Area of Science:

  • Ophthalmology
  • Oncology
  • Molecular Biology

Background:

  • Uveal melanoma (UM) is the most common primary intraocular malignancy in adults.
  • UM has a very poor prognosis, necessitating novel therapeutic strategies.

Purpose of the Study:

  • To investigate the expression of somatostatin receptor types 1-5 (SSTR-1⁻5) mRNA and protein in human UM tissues and cell lines.
  • To evaluate SSTRs as potential molecular targets for UM therapy.

Main Methods:

  • Quantitative reverse transcription polymerase chain reaction (qRT-PCR) for mRNA expression.
  • Western blot analysis for protein expression.
  • Ligand competition assay to confirm receptor presence and affinity.

Main Results:

  • SSTR-2 mRNA showed higher expression in UM tissues compared to SSTR-5.
  • SSTRs were detected in 70% of UM specimens.
  • Both OCM-1 and OCM-3 UM cell lines exhibited high-affinity SSTRs, with SSTR-5 mRNA showing the highest expression and SSTR-2 and SSTR-5 proteins confirmed by western blot.

Conclusions:

  • The expression of SSTR-2 and SSTR-5 in UM suggests these receptors are viable molecular targets.
  • Targeting SSTR-2 and SSTR-5 with somatostatin (SST) analogs may offer a new therapeutic avenue for UM treatment.